BRAINSTORM CELL THERAPEUTICS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.534 USD | -2.68% |
|
-8.09% | +96.12% |
| Apr. 09 | Brainstorm Cell Therapeutics Says FDA Agrees on Design of Phase 3B ALS Trial | MT |
| Apr. 09 | Transcript : Brainstorm Cell Therapeutics Inc. - Special Call |
Chart calendar Brainstorm Cell Therapeutics Inc.
1d07e62fc06dc2f9ec6103.1augSSFkjlqFVV1shH9Yi1OTJJDhwRI9evRjAfKuR28.55zOHVAu4Rz3Fiog5zwOyR3KQNSgk1wNDZgPVZj0NiSD--k9bQb5IvYcCA~7059661bd2a164fb0694cfe32fe93acd
Upcoming events on Brainstorm Cell Therapeutics Inc.
Past events on Brainstorm Cell Therapeutics Inc.
| 2024-04-09 08:00 am | Business Update Call |
| 2024-04-01 08:05 am | Q4 2023 Earnings Release |
| 2024-03-05 | European Life Sciences CEO Forum |
| 2024-03-04 06:00 pm | MDA Clinical and Scientific Conference |
| 2024-02-28 11:20 am | European Life Sciences CEO Forum |
| 2024-02-28 07:40 am | European Life Sciences CEO Forum |
| 2023-12-17 | Annual General Meeting |
| 2023-11-14 08:30 am | Q3 2023 Earnings Call |
| 2023-11-14 07:05 am | Q3 2023 Earnings Release |
| 2023-10-18 08:30 am | Business Update Call |
| 2023-09-26 | ADCOM Conference |
| 2023-08-14 08:00 am | Q2 2023 Earnings Call |
| 2023-08-14 07:05 am | Q2 2023 Earnings Release |
| 2023-07-05 12:00 pm | Gordon Research Conference |
| 2023-06-21 09:00 am | Maxim Group Virtual Healthcare Conference |
| 2023-05-15 08:00 am | Q1 2023 Earnings Call |
| 2023-05-15 07:05 am | Q1 2023 Earnings Release |
| 2023-03-30 08:00 am | Q4 2022 Earnings Call |
| 2023-03-30 07:05 am | Q4 2022 Earnings Release |
| 2023-03-27 08:00 am | Business Update Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -23,0 -20,4 -13% | -31,7 -26,3 -20.41% | -24,5 -29,0 15.32% | -24,8 -25,9 4.18% | -21,4 -25,3 15.2% | -21,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,3 -20,5 -13.33% | -31,8 -26,1 -21.82% | -24,5 -28,7 14.93% | -24,3 -25,5 4.66% | -17,2 -25,2 31.71% | -21,9 |
|
Net income Million USD | Released Forecast Spread | -23,3 -20,2 -15.39% | -31,8 -26,1 -21.82% | -24,5 -28,7 14.93% | -24,3 -25,5 4.66% | -17,2 -23,0 25.37% | -21,9 |
|
EPS USD | Released Forecast Spread | -1,06 -0,91 -17.13% | -1,07 -0,89 -20.22% | -0,68 -0,79 13.92% | -0,66 -0,68 2.22% | -0,40 -0,56 28.57% | -0,28 |
| Announcement Date | 18/02/20 | 04/02/21 | 28/03/22 | 30/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,21 -7,17 13.3% | -5,48 -4,70 -16.49% | -7,59 -5,46 -39.14% | -6,84 -6,75 -1.39% | -4,92 -6,00 18.08% | -5,15 -6,01 14.24% | -5,45 -5,70 4.43% | -6,04 -6,00 -0.56% | -4,80 -6,33 24.1% | -4,50 | -5,20 | -5,80 | -6,40 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,19 -7,17 13.61% | -5,36 -4,70 -14.04% | -7,04 -5,46 -29.06% | -6,86 -6,75 -1.65% | -5,02 -6,00 16.37% | -5,06 -5,96 15.06% | -5,33 -5,65 5.71% | -1,23 -6,00 79.57% | -5,58 -6,33 11.87% | -4,50 | -5,20 | -5,80 | -6,40 |
|
Net income Million USD | Released Forecast Spread | -6,19 -7,17 13.61% | -5,36 -4,70 -14.04% | -7,04 -5,46 -29.06% | -6,86 -6,75 -1.65% | -5,02 -6,00 16.37% | -5,06 -5,96 15.06% | -5,33 -5,65 5.71% | -1,23 -6,00 79.57% | -5,58 -6,33 11.87% | -4,50 | -5,20 | -5,80 | -6,40 |
|
EPS USD | Released Forecast Spread | -0,17 -0,20 12.82% | -0,15 -0,13 -15.38% | -0,19 -0,15 -31.03% | -0,19 -0,18 -5.56% | -0,13 -0,15 10.34% | -0,14 -0,17 15.15% | -0,13 -0,15 10.34% | -0,03 -0,15 79.31% | -0,11 -0,13 15.38% | -0,07 | -0,07 | -0,06 | -0,07 |
| Announcement Date | 28/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 30/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | 01/04/24 | - | - | - | - |
More events
Past sector events for Brainstorm Cell Therapeutics Inc.
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
| 2024-03-27 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q4 2023 Earnings Release |
| 2024-03-27 10:25 am | PHARMARON BEIJING CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BCLI Stock
- Calendar Brainstorm Cell Therapeutics Inc.
